Fredun Pharmaceuticals Secures Orders from SEA Countries

Fredun Pharmaceuticals Limited (BSE: 539730), a leading provider of innovative healthcare solutions, has announced significant milestones in its business expansion and product development initiatives.

Breakthrough Orders from SEA Countries: Fredun Pharmaceuticals has received large orders from Southeast Asian (SEA) countries, amounting to Rs 28 crores. These orders not only demonstrate the Company's growing presence in the international markets but also hold substantial potential to scale up over the years, signifying a promising avenue for future growth and market penetration.

Innovative Ventures in Veterinary Product Development: As part of its commitment to pioneering advancements in pet and veterinary care, Fredun Pharma has initiated the development of three new molecules. These ground-breaking formulations, the first of their kind in India, are poised to revolutionize the landscape of veterinary medicine, addressing critical needs and enhancing the well-being of companion animals. This strategic endeavour underscores the Company's dedication to innovation and meeting evolving market demands in the veterinary sector.

Advancements in Bone Graft Technology: Building on the success of its bone graft products, Fredun Pharma is proud to announce widespread acceptance by medical professionals. Encouraged by this positive response, the Company is expanding its focus on bone grafts for use in orthopaedic and veterinary applications. This strategic move reflects the Company's commitment to delivering high-quality healthcare solutions that positively impact patient outcomes and advance medical practices in both human and animal healthcare domains.

Commenting on the milestone achievement, Mr. Fredun Medhora, Managing Director of Fredun Pharmaceuticals said, "These recent achievements underscore our unwavering commitment to innovation, quality, and customer satisfaction. We are excited about the opportunities presented by our expanding international footprint, pioneering developments in veterinary care, and advancements in orthopaedic applications. We remain dedicated to driving positive change in healthcare and improving the lives of patients and animals worldwide."

Shares of Fredun Pharmaceuticals Ltd was last trading in BSE at Rs. 812.85 as compared to the previous close of Rs. 834.90. The total number of shares traded during the day was 10056 in over 453 trades.

The stock hit an intraday high of Rs. 834.00 and intraday low of 792.00. The net turnover during the day was Rs. 8213119.00.

Source : Equity Bulls

Keywords

FredunPharmaceuticals INE194R01017 OrderWin SEACountries